{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T18:34:01Z","timestamp":1793126041269,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005876","name":"Research Council for Biosciences and Environment","doi-asserted-by":"publisher","award":["#270257"],"award-info":[{"award-number":["#270257"]}],"id":[{"id":"10.13039\/501100005876","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Research Council of Finland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009420","name":"Varsinais-Suomen Sairaanhoitopiiri","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009420","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011797","name":"Tyks Main Hospital","doi-asserted-by":"publisher","award":["#13821"],"award-info":[{"award-number":["#13821"]}],"id":[{"id":"10.13039\/501100011797","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ejps.2026.107659","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T14:59:19Z","timestamp":1788533959000},"page":"107659","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Systematic evaluation of propofol population pharmacokinetic models and development of a literature-supported new meta-model for critically ill preterm and term neonates"],"prefix":"10.1016","volume":"227","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3200-0649","authenticated-orcid":false,"given":"Matias","family":"Rantanen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terhi","family":"Launiainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4550-2189","authenticated-orcid":false,"given":"Mikko","family":"Niemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7872-8665","authenticated-orcid":false,"given":"Klaus T.","family":"Olkkola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3077-2725","authenticated-orcid":false,"given":"Hanna","family":"Soukka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1225-4561","authenticated-orcid":false,"given":"Teijo I.","family":"Saari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ejps.2026.107659_bib0001","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/j.1460-9592.2007.02285.x","article-title":"Maturational pharmacokinetics of single intravenous bolus of propofol","volume":"17","author":"Allegaert","year":"2007","journal-title":"Paediatr. Anaesth."},{"issue":"6","key":"10.1016\/j.ejps.2026.107659_bib0002","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1093\/bja\/aem294","article-title":"Inter-individual variability in propofol pharmacokinetics in preterm and term neonates","volume":"99","author":"Allegaert","year":"2007","journal-title":"Br. J. Anaesth."},{"issue":"6","key":"10.1016\/j.ejps.2026.107659_bib0003","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/bja\/aen276","article-title":"Urinary propofol metabolites in early life after single intravenous bolus","volume":"101","author":"Allegaert","year":"2008","journal-title":"Br. J. Anaesth."},{"issue":"2","key":"10.1016\/j.ejps.2026.107659_bib0004","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1001\/archpedi.155.2.173","article-title":"Consensus statement for the prevention and management of pain in the newborn","volume":"155","author":"Anand","year":"2001","journal-title":"Arch. Pediatr. Adolesc. Med."},{"key":"10.1016\/j.ejps.2026.107659_bib37","series-title":"NONMEM Users Guides 1989-2009)","author":"Beal","year":"2009"},{"issue":"2","key":"10.1016\/j.ejps.2026.107659_bib0006","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1208\/s12248-011-9255-z","article-title":"Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models","volume":"13","author":"Bergstrand","year":"2011","journal-title":"AAPS J."},{"issue":"5","key":"10.1016\/j.ejps.2026.107659_bib0007","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s10928-020-09695-z","article-title":"Prior information for population pharmacokinetic and pharmacokinetic\/pharmacodynamic analysis: overview and guidance with a focus on the NONMEM PRIOR subroutine","volume":"47","author":"Chan Kwong","year":"2020","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"issue":"1\u20132","key":"10.1016\/j.ejps.2026.107659_bib0008","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jchromb.2007.04.021","article-title":"Quantitative measurement of propofol and main glucuroconjugate metabolites in human plasma using solid phase extraction\u2013liquid chromatography\u2013tandem mass spectrometry","volume":"854","author":"Cohen","year":"2007","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"issue":"2","key":"10.1016\/j.ejps.2026.107659_bib0009","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.cmpb.2007.12.002","article-title":"Computing normalised prediction distribution errors to evaluate nonlinear mixed-effect models: the npde add-on package for R","volume":"90","author":"Comets","year":"2008","journal-title":"Comput. Methods Programs Biomed."},{"issue":"5","key":"10.1016\/j.ejps.2026.107659_bib0010","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1136\/archdischild-2019-318474","article-title":"Propofol for endotracheal intubation in neonates: a dose-finding trial","volume":"105","author":"de Kort","year":"2020","journal-title":"Arch. Dis. Child. Fetal Neonatal Ed."},{"issue":"5","key":"10.1016\/j.ejps.2026.107659_bib0011","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.bja.2018.01.018","article-title":"Pharmacokinetic\u2013pharmacodynamic model for propofol for broad application in anaesthesia and sedation","volume":"120","author":"Eleveld","year":"2018","journal-title":"Br. J. Anaesth."},{"issue":"3","key":"10.1016\/j.ejps.2026.107659_bib0012","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/ppe.70035","article-title":"Fenton third-generation growth charts of preterm infants without abnormal fetal growth: a systematic review and meta-analysis","volume":"39","author":"Fenton","year":"2025","journal-title":"Paediatr. Perinat. Epidemiol."},{"issue":"12","key":"10.1016\/j.ejps.2026.107659_bib0013","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1213\/00000539-198712000-00010","article-title":"Disposition of propofol administered as constant rate intravenous infusions in humans","volume":"66","author":"Gepts","year":"1987","journal-title":"Anesth. Analg."},{"issue":"4","key":"10.1016\/j.ejps.2026.107659_bib0014","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/bcp.13160","article-title":"Scaling clearance in paediatric pharmacokinetics: all models are wrong, which are useful?","volume":"83","author":"Germovsek","year":"2017","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejps.2026.107659_bib0015","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s40262-018-0659-0","article-title":"Pharmacokinetic\u2013pharmacodynamic modeling in pediatric drug development, and the importance of standardized scaling of clearance","volume":"58","author":"Germovsek","year":"2019","journal-title":"Clin. Pharmacokinet."},{"issue":"6","key":"10.1016\/j.ejps.2026.107659_bib0016","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2006-2708","article-title":"Propofol compared with the morphine, atropine, and suxamethonium regimen as induction agents for neonatal endotracheal intubation: a randomized, controlled trial","volume":"119","author":"Ghanta","year":"2007","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.ejps.2026.107659_bib0017","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1111\/bcp.15091","article-title":"Evaluation of published population pharmacokinetic models to inform tacrolimus dosing in adult heart transplant recipients","volume":"88","author":"Kirubakaran","year":"2022","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2026.107659_bib0018","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ejps.2016.06.026","article-title":"Pharmacokinetic models of morphine and its metabolites in neonates: systematic comparisons of models from the literature, and development of a new meta-model","volume":"92","author":"Kn\u00f8sgaard","year":"2016","journal-title":"Eur. J. Pharm. Sci."},{"issue":"5","key":"10.1016\/j.ejps.2026.107659_bib0019","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jpba.2017.07.029","article-title":"Volumetric absorptive microsampling: current advances and applications","volume":"147","author":"Kok","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"3","key":"10.1016\/j.ejps.2026.107659_bib0020","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1542\/peds.2009-2863","article-title":"Premedication for nonemergency endotracheal intubation in the neonate","volume":"125","author":"Kumar","year":"2010","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.ejps.2026.107659_bib0021","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1001\/jamapediatrics.2013.4208","article-title":"Drug labeling and exposure in neonates","volume":"168","author":"Laughon","year":"2014","journal-title":"JAMA Pediatr."},{"issue":"4","key":"10.1016\/j.ejps.2026.107659_bib0022","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s13318-016-0372-z","article-title":"Prediction of clearance, volume of distribution, and half-life of drugs in extremely low to low birth weight neonates: an allometric approach","volume":"42","author":"Mahmood","year":"2017","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"issue":"7","key":"10.1016\/j.ejps.2026.107659_bib0023","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1124\/dmd.111.043752","article-title":"Neonatal development of hepatic UGT1A9: implications of pediatric pharmacokinetics","volume":"40","author":"Miyagi","year":"2012","journal-title":"Drug Metab. Dispos."},{"issue":"9","key":"10.1016\/j.ejps.2026.107659_bib0024","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1055\/s-0034-1543987","article-title":"Premedication use before nonemergent intubation in the newborn infant","volume":"32","author":"Muniraman","year":"2015","journal-title":"Am. J. Perinatol."},{"issue":"2","key":"10.1016\/j.ejps.2026.107659_bib0025","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/psp4.12161","article-title":"Model evaluation of continuous data pharmacometric models: metrics and graphics","volume":"6","author":"Nguyen","year":"2017","journal-title":"CPT Pharmacomet. Syst. Pharmacol."},{"issue":"3","key":"10.1016\/j.ejps.2026.107659_bib0026","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1046\/j.1365-2125.2001.00344.x","article-title":"Involvement of human liver cytochrome P450 2B6 in the metabolism of propofol","volume":"51","author":"Oda","year":"2001","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2026.107659_bib0027","series-title":"RStudio: Integrated Development Environment for R [Software]","year":"2025"},{"key":"10.1016\/j.ejps.2026.107659_bib0028","series-title":"R: A Language and Environment For Statistical Computing","year":"2024"},{"issue":"12","key":"10.1016\/j.ejps.2026.107659_bib0029","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1007\/s40262-018-0672-3","article-title":"Clinical pharmacokinetics and pharmacodynamics of propofol","volume":"57","author":"Sahinovic","year":"2018","journal-title":"Clin. Pharmacokinet."},{"issue":"4","key":"10.1016\/j.ejps.2026.107659_bib0030","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1111\/bcp.14620","article-title":"Population pharmacokinetics of propofol in neonates and infants: gestational and postnatal age to determine clearance maturation","volume":"87","author":"Sandra","year":"2021","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.ejps.2026.107659_bib0031","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/bja\/aer198","article-title":"Performance evaluation of paediatric propofol pharmacokinetic models in healthy young children","volume":"107","author":"Sep\u00falveda","year":"2011","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.ejps.2026.107659_bib0032","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jpeds.2016.07.049","article-title":"Propofol dose-finding to reach optimal effect for (semi-)elective intubation in neonates","volume":"179","author":"Smits","year":"2016","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ejps.2026.107659_bib0034","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s40262-024-01444-6","article-title":"All you need to know about allometric scaling: an integrative review on the theoretical basis, empirical evidence, and application in Human pharmacology","volume":"64","author":"van Valkengoed","year":"2025","journal-title":"Clin. Pharmacokinet."},{"issue":"7","key":"10.1016\/j.ejps.2026.107659_bib0035","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s40261-013-0097-6","article-title":"Developmental changes in morphine clearance across the entire paediatric age range are best described by a bodyweight-dependent exponent model","volume":"33","author":"Wang","year":"2013","journal-title":"Clin. Drug Investig."},{"issue":"1","key":"10.1016\/j.ejps.2026.107659_bib0036","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/bcp.12180","article-title":"The allometric exponent for scaling clearance varies with age: a study on seven propofol datasets ranging from preterm neonates to adults","volume":"77","author":"Wang","year":"2014","journal-title":"Br. J. Clin. Pharmacol."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098726002332?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098726002332?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:54:47Z","timestamp":1793123687000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098726002332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":35,"alternative-id":["S0928098726002332"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2026.107659","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systematic evaluation of propofol population pharmacokinetic models and development of a literature-supported new meta-model for critically ill preterm and term neonates","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2026.107659","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107659"}}